The purpose of this study was to determine the prevalence and subtypes of amyloid in tenosynovial biopsies of patients undergoing carpal tunnel release (CTR).
A retrospective review was performed involving patients who underwent CTR from June 2020 to July 2021. Prior to this period, a protocol had been established to obtain routine intraoperative tenosynovial biopsies. Tenosynovium was preserved in formalin and stained with Congo red for amyloid. Positive specimens were sent to an external laboratory for confirmation and subtyping by mass spectrometry. Men 50 years or older and women 60 or older were included for analysis. Acute, traumatic, and revision cases were excluded.
Of 185 patients who underwent CTR with tenosynovial biopsy, 54 (29%) demonstrated positive Congo red stain, confirmed by the external laboratory. A subtype analysis revealed wild-type transthyretin (TTR) in 44 patients (80%), mixed wild-type TTR with κ light chains in 1 patient, and hereditary TTR in 1 patient. Patients with positive specimens were significantly older than those who tested negative (77 vs 68 years, respectively), and positivity increased by decade for both sexes. Male sex, atrial fibrillation, and spinal stenosis were significantly more prevalent among positive cases. There were no complications from the biopsies.
We confirmed evidence of amyloidosis in the tenosynovium of 29% of men 50 years or older and women 60 or older who underwent CTR. The majority demonstrated wild-type TTR. As these patients are at risk of developing cardiomyopathy, there is an opportunity for early detection, monitoring, and interventions known to improve outcomes. Considering the low cost of Congo red staining and the potential value of subtyping with regard to treatment of cardiomyopathy, our findings support routine tenosynovial biopsy during CTR in patients who meet the age criteria.
Type of study/level of evidence
Differential diagnosis or symptom prevalence study II.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Hand Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Orthopaedic manifestations of amyloidosis.J Am Acad Orthop Surg. 2021; 29: e488-e496
- Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis.J Hand Surg Am. 2019; 44: 868-876
- Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release.J Am Coll Cardiol. 2018; 72: 2040-2050
- CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis.N Engl J Med. 2021; 385: 493-502
- Diagnosing systemic amyloidosis presenting as carpal tunnel syndrome: a risk nomogram to guide biopsy at time of carpal tunnel release.J Bone Joint Surg Am. 2021; 103: 1284-1294
- The amyloidogenic V122I transthyretin variant in elderly Black Americans.N Engl J Med. 2015; 372: 21-29
- Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery.BMC Musculoskelet Disord. 2021; 2251
- High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly.Hum Pathol. 2011; 42: 1785-1791
- ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin.Amyloid. 2013; 20: 1-6
- Histology of the transverse carpal ligament and flexor tenosynovium in idiopathic carpal tunnel syndrome.J Hand Surg Am. 1998; 23: 1015-1024
Published online: April 22, 2022
Accepted: February 16, 2022
Received: August 10, 2021
No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.
© 2022 by the American Society for Surgery of the Hand. All rights reserved.